Regulatory
Janssen’s Darzalex (daratumumab) Combination Therapy Receives FDA’s Approval for Frontline
Shots: The approval is based on P-III CASSIOPEIA (MMY3006) study involve assessing of Darzalex + bortezomib, thalidomide and dexamethasone (VTd) vs VTd in 1,085 newly diagnosed patients with previously untreated […]readmore
